0145 First safety data from a randomised phase III trial comparing adjuvant epirubicin–cyclophosphamide → docetaxel (EC → T) vs ET → capecitabine (X) in N+ operable breast cancer (BC)
Titel:
0145 First safety data from a randomised phase III trial comparing adjuvant epirubicin–cyclophosphamide → docetaxel (EC → T) vs ET → capecitabine (X) in N+ operable breast cancer (BC)
Auteur:
Martín, M. Lluch, A. Ruiz-Simón, A. Ribelles, N. Ruiz-Borrego, M. Rodríguez-Lescure, A. Muñoz, M. Ramos, M. González, S. Margelí, M.